Diabetes Board decisions

The Board denied the veteran's claim for an effective date prior to February 21, 2020, for a 100% combined rating. The evidence did not support a higher rating before that date.

The veteran's claim for service connection for colon cancer was remanded. The veteran was granted an increased rating of 50 percent for unspecified trauma and stressor related disorder, but denied increases for diabetes and upper extremity neuropathy. Increased ratings were granted for lower extremity neuropathy.

The veteran is granted a rating for total disability based on individual unemployability due solely to service-connected PTSD and special monthly compensation (SMC) based on housebound status, effective February 1, 2022.

The Board granted service connection for multiple myeloma, hypertension, diabetes mellitus type 2, and a kidney disability.

The veteran's claims for higher ratings for sinusitis, diabetes, and allergic rhinitis were denied. A rating of 10 percent was granted for chronic bronchitis. Claims for service connection for night sweats and an earlier effective date for prostate cancer were also denied.

The appeal for service connection of diabetes mellitus was dismissed because the veteran did not file an appeal to the Board for review of his claim.

The veteran's claim for service connection for tinnitus was granted. Claims for bilateral optic nerve cupping, bilateral retinal detachment, and right ear hearing loss disability were denied. Other claims were remanded for further action.

The Veteran's claims for service connection for basal cell carcinoma, hypertension, cerebrovascular accident, and deep vein thrombosis were granted. The claim for diabetes mellitus was dismissed.

The Board denied service connection for all claimed conditions and denied higher ratings and earlier effective dates for the foot conditions.

The veteran's claim for an initial compensable rating for bilateral hearing loss was denied. The claims for higher ratings for diabetes mellitus, type II, and peripheral neuropathy were remanded.

The veteran's claim for service connection for restless leg syndrome (RLS) as secondary to diabetes mellitus, type II is granted. The Board found that the veteran's RLS was caused by his service-connected diabetes.

The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance from April 25, 2014 through June 17, 2015.

The Board remands the issues of entitlement to service connection for coronary artery disease and diabetes mellitus, to include as due to herbicide agent exposure, for further development.

The Board denied service connection for obstructive sleep apnea, Parkinson's disease with tremors, gastroesophageal reflux disease (GERD), and a respiratory disability. It also denied increased ratings for coronary artery disease, diabetes mellitus, posttraumatic stress disorder (PTSD), and an earlier effective date for TDIU.

The Board denied the veteran's claims for increased ratings and service connection, finding no evidence to support a link between his claimed conditions and military service.

The veteran's claim for service connection of diabetes mellitus, type II as secondary to obstructive sleep apnea was granted.

The Board denied the veteran's claims for service connection for several conditions, stating that new and relevant evidence was not received.

The Board denied the veteran's appeal for an effective date earlier than August 10, 2022, for service connection of prostate cancer, hypertension, diabetes mellitus type 2, arteriosclerotic heart disease, erectile dysfunction, and special monthly compensation (SMC) based on loss of use of creative organ.

The VA properly revised the rating for Meniere's disease to 30% due to a clear and unmistakable error. The veteran is granted SMC benefits based on the need for regular aid and attendance. The claim for SMC based on housebound status is dismissed as moot, and the claim for service connection for COPD is dismissed. The claim for service connection for hypertension is remanded.

The Board remanded the veteran's claims for a 10 percent evaluation based on multiple service-connected disabilities, service connection for diabetes mellitus type II, and initial compensable evaluations for erectile dysfunction and papillary urothelial carcinoma. The Board found errors in the duty to assist and ordered additional actions.